Single daily dose of cefodizime in patients with community-acquired pneumonia: an open-label, controlled, randomized study
- 30 June 1995
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 17 (3) , 413-424
- https://doi.org/10.1016/0149-2918(95)80106-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cefodizime host-defence enhancement: Considerations of dose-response relationships in healthy volunteersInfection, 1992
- In vivo activity of cefodizimeInfection, 1992
- In vitro activity of cefodizimeInfection, 1992
- Ceftibuten—in-vitro activity against respiratory pathogens, β-lactamase stability and mechanism of actionJournal of Antimicrobial Chemotherapy, 1990
- Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patientsJournal of Antimicrobial Chemotherapy, 1990
- Cefodizime, an aminothiazolylcephalosporin. II. Comparative studies on the pharmacokinetic behavior in laboratory animals.The Journal of Antibiotics, 1984
- Cefodizime, an aminothiazolylcephalosporin. I. In vitro activity.The Journal of Antibiotics, 1984
- Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system.The Journal of Antibiotics, 1984
- Comparative beta-lactamase hydrolysis of and inhibition by 7-aminothiazolyl alpha-methoxyimino cephalosporinsInfection, 1982
- In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporinAntimicrobial Agents and Chemotherapy, 1981